Neurocognitive impairments in eating disorders patients with and without comorbid food addiction.

dc.contributor.authorMunguía, Lucero
dc.contributor.authorGranero, Roser
dc.contributor.authorSupit, Kim
dc.contributor.authorLucas, Ignacio
dc.contributor.authorGearhardt, Ashley N.
dc.contributor.authorJimenez Murcia, Susana
dc.contributor.authorFernández Aranda, Fernando
dc.date.accessioned2026-03-16T15:56:02Z
dc.date.available2026-03-16T15:56:02Z
dc.date.issued2025-12-08
dc.date.updated2026-03-16T15:56:05Z
dc.description.abstractBackground Research into the presence of Food Addiction (FA) in Eating Disorders (EDs) has gained increasing attention due to its association with greater symptom severity and poorer treatment outcomes. While the clinical and psychopathological significance of FA in EDs is well established, its neurocognitive impact remains largely unexplored. This study had two primary aims: (1) to examine the psychopathological profile and neurocognitive performance of patients with Eating Disorders (EDs), comparing those with Food Addiction (ED FA+) to those without (ED FA−), alongside a Healthy Control (HC) group; and (2) to explore potential correlations between neurocognitive performance and clinical-psychopathological variables. Methods The sample consisted of N=152 female participants that met the following conditions: EDs FA+ (N=65), EDs FA- (N=24), and HC (N=63). All participants completed a comprehensive battery of questionnaires, including the Yale Food Addiction Scale 2.0. (YFAS-2), and others for the assessment of the eating disorder symptoms, general psychopathology, impulsivity and emotion regulation. Decision-making and inhibitory control were assessed using the Iowa Gambling Task and The Connors Continuous Performance Test II. Results Neurocognitive differences were moderate, with lower IGT performance in Block 3 and greater CPT variability, especially in the ED FA+group. Although the ED FA+group presented a more severe clinical profile—characterized by heightened eating symptomatology and general psychopathology (ED F – vs. ED FA+: EDI-2 Total score p 0.001 d 0.95; SCL-90R Global Severity Index p 0.008 d 071)—this was not directly associated with greater cognitive impairment. Conclusions The results underscore the need to assess Food Addiction in ED patients, as its presence may exacerbate symptom severity. Additionally, the results suggest that patients with EDs could benefit from incorporating cognitive rehabilitation into their treatment plans, regardless of FA status.
dc.format.extent15 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec766692
dc.identifier.issn2050-2974
dc.identifier.urihttps://hdl.handle.net/2445/228151
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s40337-025-01494-6
dc.relation.ispartofJournal of Eating Disorders, 2025, vol. 14
dc.relation.urihttps://doi.org/10.1186/s40337-025-01494-6
dc.rightscc-by (c) Munguía L et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceArticles publicats en revistes (Ciències Clíniques)
dc.subject.classificationTrastorns de la cognició
dc.subject.classificationTrastorns de la gana
dc.subject.otherCognition disorders
dc.subject.otherAppetite disorders
dc.titleNeurocognitive impairments in eating disorders patients with and without comorbid food addiction.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
922371.pdf
Mida:
1.72 MB
Format:
Adobe Portable Document Format